| |
Wednesday, February 12, 2025 | 10am ET / 7am PT If you are a company developing advanced therapies, don’t miss this webinar to learn about packaging innovations and aseptic filling solutions that meet the demands of emerging therapies and ensure product integrity, safety and efficiency.
|
|
|
Wednesday, February 19, 2025 | 11am ET / 8am PT This webinar takes a deep dive into effective formulation strategies to overcome current solubility and bioavailability hurdles. Join us to explore the latest advancements in bioavailability enhancement technologies and critical factors for selecting the right formulation approach. Register now.
|
|
| By Darren Incorvaia The Centers for Disease Control and Prevention has asked its staff to withdraw any scientific papers currently under consideration for internal or external publication so that certain words can be removed, according to several reports. |
|
|
|
By Kevin Dunleavy Despite recent evidence of its financial turnaround, Thermo Fisher’s layoff spree will continue into 2025. According to a Massachusetts Worker Adjustment and Retraining Notification report from last week, the company will lay off 300 workers at its viral vector manufacturing facilities in Cambridge and Plainville |
By James Waldron Astellas is preparing a significant shake-up of its top tier roles, including ushering out its current Chief Scientific Officer and Chief Manufacturing Officer. |
By Angus Liu As the major cost-cutting initiative at Bristol Myers Squibb rolls on, the company has launched another round of layoffs in its home state of New Jersey. |
|
Thursday, February 20, 2025 | 1pm ET / 10am PT ALS remains one of the most complex neurological diseases to understand and treat. Join industry experts to learn about the latest advancements in ALS research, with exclusive insights into the latest scientific progress shaping the future of ALS therapies. Register now.
|
|
By Nick Paul Taylor Pfizer tallied up $1.2 billion in impairment charges in response to changes in development plans and commercial forecasts for Seagen-acquired ADCs. |
By Fraiser Kansteiner The recent decline of Merck & Co.’s HPV vaccine Gardasil in China has come to a head as the New Jersey drug giant is suspending shipments to the world’s second-most populous country. |
By Conor Hale The news comes just days after Baxter completed the sale of its Vantive kidney care unit through a $3.8 billion deal with the Carlyle Group that had been in the works since last summer. |
By Fraiser Kansteiner With President Donald Trump’s tariffs about to take hold, industry groups are warning that the move could hamstring U.S. pharmaceutical supplies and productivity, and put an extra strain on patients’ wallets, too. |
By Nick Paul Taylor Novo Nordisk’s cannabinoid CB1 receptor blocker has run into another problem. Months after sharing obesity data that left investors underwhelmed, the Danish drugmaker has reported the failure of a midphase diabetic kidney disease trial of the molecule. |
By Nick Paul Taylor Novartis has become the latest drugmaker to get in trouble over an employee’s LinkedIn likes. The U.K. drug marketing watchdog ruled the employee’s act broke the rules on advertising prescription medicines to the public but placed the blame on the worker, not the company. |
Fierce podcastsDon’t miss an episode |
| | As the first two weeks of his second term showed, keeping up with Trump’s actions—and their ramifications—requires full-time focus. A policy expert breaks down how Congress might approach reform in 2025. |
|
|---|
|
|
|
Wednesday, February 26, 2025 | 12pm ET / 9am PT In today’s world, life sciences and healthcare companies face major challenges — managing complex datasets, accelerating drug discovery, and advancing precision research. Register for our webinar to learn how to overcome overcome these challenges using AI cloud infrastructure and advanced machine learning tools.
|
|
| WhitepaperThis paper reviews key developments in the oncology market during 2024 and outlines what they mean for the future. Presented by Blue Matter, strategic consultants in the life sciences |
| WhitepaperThere’s so much that goes into making sure your therapy maximizes impact every step of the way. Sponsored by: Accredo By Evernorth |
| ResearchStudy shows significant Rx growth using new EHR marketing technique. Sponsored by: Veradigm |
| |
|
